Literature DB >> 21058914

Antimicrobial-resistant nocardia isolates, United States, 1995-2004.

Kristin Broome Uhde1, Sonal Pathak, Isaac McCullum, Deanna P Jannat-Khah, Sean V Shadomy, Clare A Dykewicz, Thomas A Clark, Theresa L Smith, June M Brown.   

Abstract

We conducted a 10-year retrospective evaluation of the epidemiology and identification of Nocardia isolates submitted to the Centers for Disease Control and Prevention for antimicrobial susceptibility testing. The species most commonly identified were N. nova (28%), N. brasiliensis (14%), and N. farcinica (14%). Of 765 isolates submitted, 61% were resistant to sulfamethoxazole and 42% were resistant to trimethoprim-sulfamethoxazole.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21058914     DOI： 10.1086/657399

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  64 in total

1.  A fatal case of pulmonary nocardiosis.

Authors:  Mahantesh Patil; Shivaprasad C; Jaicob Varghese; Natarajan Rajagopalan
Journal:  BMJ Case Rep       Date:  2012-02-25

Review 2.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

3.  Intractable cerebral Nocardia mexicana in a GvHD patient successfully treated with linezolid.

Authors:  A Majeed; A Mushtaq; T Zangeneh; R E Ramahi; S Batool; H Khan; A Latif; V Kapoor; F Anwer
Journal:  Bone Marrow Transplant       Date:  2017-08-07       Impact factor: 5.483

4.  Nocardia thailandica Pulmonary Nocardiosis in a Post-Solid Organ Transplant Patient.

Authors:  Joseph Canterino; Alberto Paniz-Mondolfi; Barbara A Brown-Elliott; Wilson Vientos; Ravikiran Vasireddy; Richard J Wallace; Sheldon Campbell
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

5.  Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species.

Authors:  Patricia S Conville; Barbara A Brown-Elliott; Richard J Wallace; Frank G Witebsky; Deloris Koziol; Geraldine S Hall; Scott B Killian; Cindy C Knapp; David Warshauer; Tam Van; Nancy L Wengenack; Sharon Deml; Gail L Woods
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

Review 6.  Nocardiosis: A Neglected Disease.

Authors:  Shalini Dewan Duggal; Tulsi Das Chugh
Journal:  Med Princ Pract       Date:  2020-05-18       Impact factor: 1.927

7.  Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis.

Authors:  Lisa R McTaggart; Jennifer Doucet; Maria Witkowska; Susan E Richardson
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

8.  Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.

Authors:  Chih-Cheng Lai; Wei-Lun Liu; Wen-Chien Ko; Yen-Hsu Chen; Hon-Ren Tan; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

Review 9.  Other HIV-associated pneumonias.

Authors:  Jakrapun Pupaibool; Andrew H Limper
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

10.  Molecular identification and susceptibility pattern of clinical Nocardia species: Emergence of Nocardia crassostreae as an agent of invasive nocardiosis.

Authors:  Saad J Taj-Aldeen; Anand Deshmukh; Sanjay Doiphode; Atqah Abdul Wahab; Mona Allangawi; Ahmed Almuzrkchi; Corné H Klaassen; Jacques F Meis
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.